Insider purchase: CE director Ganesh Moorthy adds 1,000 shares

Rhea-AI Filing Summary

Insider purchase disclosed: Celanese Corporation director Ganesh Moorthy bought 1,000 shares of CE common stock on 08/14/2025 at a reported price of $40.942 per share, increasing his direct holdings to 6,015 shares. The filing also shows an indirect holding of 3,000 shares held by the Ganesh and Hema Moorthy Revocable Living Trust. The Form 4 was signed by an attorney-in-fact on 08/18/2025.

Insights

Securities Analyst

TL;DR: A director purchased a small number of shares, indicating modest insider buying but not clearly material.

The 1,000-share purchase at $40.942 increases the reporting persons direct stake to 6,015 shares, with an additional 3,000 shares held indirectly via a revocable trust. The transaction is a straightforward open-market purchase reported on Form 4 and executed under a standard disclosure filing. There are no derivative transactions or disposals reported. For investors, this is a routine insider purchase disclosure without further detail on intent or a Rule 10b5-1 plan.

Corporate Governance Expert

TL;DR: Governance disclosure is complete and standard; no red flags in the filing.

The Form 4 identifies the reporting person as a director and provides the transaction date, price, and post-transaction holdings. The filing is signed by an attorney-in-fact, which is acceptable when authorized. There are no amendments, derivative positions, or indications of coordinated group filings. The disclosure meets Section 16 reporting requirements as presented.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORTHY GANESH

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		P		1,000	A	$40.942	6,015	D
Common Stock								3,000	I	By Ganesh and Hema Moorthy Revocable Living Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Ganesh Moorthy	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese (CE) report on Form 4?

Director Ganesh Moorthy purchased 1,000 shares of Celanese common stock on 08/14/2025 at a price of $40.942 per share.

How many Celanese shares does Ganesh Moorthy own after the reported transaction?

After the purchase, Ganesh Moorthy directly beneficially owns 6,015 shares, plus 3,000 shares indirectly via the Ganesh and Hema Moorthy Revocable Living Trust.

Was the Form 4 for Celanese (CE) amended or filed jointly?

No amendment date is provided and the form indicates it was filed by one reporting person (individual filing).

Are there any derivative transactions or dispositions reported in this Form 4?

No. Table II shows no derivative securities and Table I reports only the single non-derivative purchase; there are no disposals reported.

Who signed the Form 4 for the Celanese insider filing?

The Form 4 is signed by Christine Dryden, Attorney-in-Fact for Ganesh Moorthy on 08/18/2025.